Abiopharma

🔍 Kim Joo Mi (Executive)

Company: QUALYS, INC. (QLYS)

Report Date: 2026-09-02

Detailed Transactions and Holdings:

• Sold 293 shares of Common Stock at $167.4897 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 75,450.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 166 shares of Common Stock at $168.754 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 75,284.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 204 shares of Common Stock at $170.0475 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 75,080.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 265 shares of Common Stock at $171.1442 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 74,815.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 102 shares of Common Stock at $172.37 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 74,713.00 | transaction_form_type: 4 | Footnotes: F1, F6

Footnotes:

• F1: The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2025.
• F2: The sale price represents the weighted average price of the shares sold ranging from $166.97 to $167.85 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
• F3: The sale price represents the weighted average price of the shares sold ranging from $168.37 to $169.01 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
• F4: The sale price represents the weighted average price of the shares sold ranging from $169.68 to $170.64 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
• F5: The sale price represents the weighted average price of the shares sold ranging from $170.69 to $171.49 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
• F6: The sale price represents the weighted average price of the shares sold ranging from $172.15 to $172.59 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.